- Home
- VRME vs NCNA Comparison
VRME vs NCNA Comparison
Compare VRME & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRME | NCNA |
|---|---|---|
| Founded | 1999 | 1997 |
| Country | United States | United Kingdom |
| Employees | 30 | 12 |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0M | 9.7M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | VRME | NCNA |
|---|---|---|
| Price | $0.65 | $2.32 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 62.5K | 36.7K |
| Earning Date | 05-13-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $36.85 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.59 | $0.03 |
| 52 Week High | $1.51 | $10.00 |
Technical Indicators
Market Signals| Indicator | VRME | NCNA |
|---|---|---|
| Relative Strength Index (RSI) | 39.08 | 59.61 |
| Support Level | $0.64 | $1.97 |
| Resistance Level | $0.93 | $2.28 |
| Average True Range (ATR) | 0.05 | 0.18 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 27.28 | 80.36 |
Price Performance
Historical ComparisonAbout VRME VerifyMe Inc.
VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.